Selectivity index, ratio of CC50 for human HepG2 2.2.15 to IC50 of Antiviral activity against lamivudine/entecavir-resistant HBV rtL180M/rtM204V/rtT18...

Basic Information

ID: ALA4688354

Type: Toxicity

Description: Selectivity index, ratio of CC50 for human HepG2 2.2.15 to IC50 of Antiviral activity against lamivudine/entecavir-resistant HBV rtL180M/rtM204V/rtT184L mutant infected in human HepG2 2.2.15 cells assessed as inhibition of viral DNA replication measured after incubation of 72 hrs by RT-PCR analysis relative to control

Format: BAO_0000219

Target:  Unchecked(ALA612545)

Document:  ALA4680304

Selectivity index, ratio of CC50 for human HepG2 2.2.15 to IC50 of Antiviral activity against lamivudine/entecavir-resistant HBV rtL180M/rtM204V/rtT184L mutant infected in human HepG2 2.2.15 cells assessed as inhibition of viral DNA replication measured after incubation of 72 hrs by RT-PCR analysis relative to control: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
548.265.215.21
497.364.044.04